Clinical Trials Directory

Trials / Not Yet Recruiting

Not Yet RecruitingNCT06745050

Hybrid Type-1 Effectiveness-Implementation Trial of Motivation Matters!

Hybrid Type-1 Effectiveness-Implementation Trial of Motivation Matters! A Theory-Based mHealth Intervention to Support Early Antiretroviral Adherence in HIV+ African Women Who Engage in Sex Work

Status
Not Yet Recruiting
Phase
N/A
Study type
Interventional
Enrollment
350 (estimated)
Sponsor
University of Washington · Academic / Other
Sex
Female
Age
18 Years
Healthy volunteers
Not accepted

Summary

The goal of this clinical trial is to learn if an interactive mHealth intervention will be effective in helping HIV-positive women in high-burden settings who are initiating antiretroviral therapy (ART) take their ART regularly as prescribed, effectively reducing their viral load. The main question it aims to answer is: \- Compared to standard of care, will Motivation Matters! (MM!) be significantly more effective at achieving undetectable viral load in women with HIV by month six. Researchers will compare the undetectable HIV viral load in women who receive individualized text messages (intervention group) in addition to standard care to those who receive standard care alone (control group). Participants in the intervention group will receive three messages per week in month one, then two messages per week for the six-month intervention period. Participants will be asked to send a brief, standardized reply to each message, indicating that they are doing well or that they have a question or problem. Regardless of study arm, women will receive ART and counseling consistent with Kenyan guidelines.

Conditions

Interventions

TypeNameDescription
BEHAVIORALText message mHealth Evidence-based interventionMM! includes three messages per week in month one, then two messages per week for the six-month intervention period. Earlier messages include more informational and motivational content, while later messages include more behavioral skills.

Timeline

Start date
2026-01-01
Primary completion
2029-12-31
Completion
2029-12-31
First posted
2024-12-20
Last updated
2025-10-03

Locations

1 site across 1 country: Kenya

Source: ClinicalTrials.gov record NCT06745050. Inclusion in this directory is not an endorsement.